MedTrace Logo

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

NCT06859515 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2025-08-15

No results posted yet for this study

Summary

This is a long-term, safety and efficacy follow-up study of patients in the EXG102-031-111 gene therapy clinical trial for wAMD. Patients will complete visits from the parent study, and then into this long-term follow-up study for continuous safety monitoring for up to 5 years.

Conditions

Interventions

OTHER

No intervention, only for observational studies

No intervention, only for observational studies

Sponsors & Collaborators

  • Peking University People's Hospital

    collaborator OTHER

  • Hangzhou Jiayin Biotech Ltd

    lead INDUSTRY

Principal Investigators

  • Mingwei ZHAO, PhD · Peking University People's Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-13
Primary Completion
2030-05-15
Completion
2030-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06859515 on ClinicalTrials.gov